Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 1453
  • Home
  • Print this page
  • Email this page

    Article Cited by others

CURRENT OPHTHALMOLOGY

Eales' disease

Das Taraprasad, Biswas Jyotirmay, Kumar Atul, Nagpal P N, Namperumalsamy P, Patnaik Bijayananda, Tewari H K

Year : 1994| Volume: 42| Issue : 1 | Page no: 3-18

   This article has been cited by
 
1 Eales disease 10 years experience with a rare disease | [Morbus Eales 10 Jahre Erfahrung mit einem seltenen Krankheitsbild]
Stoffelns, B.M., Kramann, C., Schoepfer, K.
Klinische Monatsblatter fur Augenheilkunde. 2009; 226(4): 299-304
[Pubmed]  [Google Scholar]
2 Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease
Angayarkanni, N., Selvi, R., Pukhraj, R., Biswas, J., Bhavesh, S.J., Tombran-Tink, J.
Journal of Ocular Biology, Diseases, and Informatics. 2009; 2(1): 20-28
[Pubmed]  [Google Scholar]
3 Correspondence
Querques, G., Noci, N.D.
Retina. 2009; 29(1): 121-123
[Pubmed]  [Google Scholar]
4 Bevacizumab (Avastin) for the Treatment of Ocular Disease
Gunther, J.B., Altaweel, M.M.
Survey of Ophthalmology. 2009; 54(3): 372-400
[Pubmed]  [Google Scholar]
5 Surgical outcomes for vitrectomy in Ealesę disease
Shukla, D., Kanungo, S., Prasad, N.M., Kim, R.
Eye. 2008; 22(7): 900-904
[Pubmed]  [Google Scholar]
6 Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and ealesę disease
Murugeswari, P., Shukla, D., Rajendran, A., Kim, R., Namperumalsamy, P., Muthukkaruppan, V.
Retina. 2008; 28(6): 817-824
[Pubmed]  [Google Scholar]
7 Eales disease and current therapies
Gong, Y., Wei, S.-H.
International Journal of Ophthalmology. 2008; 8(2): 369-371
[Pubmed]  [Google Scholar]
8 Intravitreal steroids may facilitate treatment of Ealesę disease (idiopathic retinal vasculitis): An interventional case series
Ishaq, M., Feroze, A.H., Shahid, M., Baig, M.A., Ameen, S.S., Feroze, S.H., Chishti, R.A.
Eye. 2007; 21(11): 1403-1405
[Pubmed]  [Google Scholar]
9 New classification system-based visual outcome in Ealesę disease
Saxena, S., Kumar, D.
Indian Journal of Ophthalmology. 2007; 55(4): 267-269
[Pubmed]  [Google Scholar]
10 Association of mycobacteria with Ealesę disease
Therese, K.L., Deepa, P., Therese, J., Bagyalakshmi, R., Biswas, J., Madhavan, H.N.
Indian Journal of Medical Research. 2007; 126(1): 56-62
[Pubmed]  [Google Scholar]
11 Ealesę disease: Oxidant stress and weak antioxidant defence
Ramakrishnan, S., Rajesh, M., Sulochana, K.
Indian Journal of Ophthalmology. 2007; 55(2): 95-102
[Pubmed]  [Google Scholar]
12 Rapid regression of disc and retinal neovascularization in a case of Eales disease after intravitreal bevacizumab [3]
Kumar, A., Sinha, S.
Canadian Journal of Ophthalmology. 2007; 42(2): 335-336
[Pubmed]  [Google Scholar]
13 Intravitreal steroids and Ealesę disease
Shahid, M., Feroze, A.H., Ishaq, M., Baig, M.A., Feroze, S.H.
Journal of the Pakistan Medical Association. 2007; 57(4): 208-209
[Pubmed]  [Google Scholar]
14 Eales disease
Ferrer, E., Moral, Ma.Ą.
Drugs of the Future. 2007; 32(5): 463-467
[Pubmed]  [Google Scholar]
15 Association of retinal vasculitis (Ealesę disease) and Meniere-like vestibulocochlear symptoms
Wagner, W., Fehrmann, A.
European Archives of Oto-Rhino-Laryngology. 2006; 263(2): 100-104
[Pubmed]  [Google Scholar]
16 A comparative study of epiretinal membranes associated with Ealesę disease: A clinicopathologic evaluation
Majji, A.B., Vemuganti, G.K., Shah, V.A., Singh, S., Das, T., Jalali, S.
Eye. 2006; 20(1): 46-54
[Pubmed]  [Google Scholar]
17 Decreased platelet membrane fluidity in retinal periphlebitis in Ealesę disease
Saxena, S., Srivastava, P., Kumar, D., Khanna, V.K., Seth, P.K.
Ocular Immunology and Inflammation. 2006; 14(2): 113-116
[Pubmed]  [Google Scholar]
18 Epidemiology study of Eales disease and its risk factors in healthy young men
Xiao, J., Wei, S.-H., Wang, J., He, Y.
Journal of Jilin University Medicine Edition. 2006; 32(1): 157-159
[Pubmed]  [Google Scholar]
19 Role of antitubercular therapy in Ealesę disease
Sharma, Y.R., Krishna, K.R., Tewari, H.K., Rattan, A., Singh, D.V.
JK Science. 2005; 7(4): 208-211
[Pubmed]  [Google Scholar]
20 The topographic distribution of retinal neovascularization in Ealesę disease
Saxena, S., Kumar, D.
Annals of Ophthalmology. 2005; 37(4): 273-275
[Pubmed]  [Google Scholar]
21 A new staging system for idiopathic retinal periphlebitis
Saxena, S., Kumar, D.
European Journal of Ophthalmology. 2004; 14(3): 236-239
[Pubmed]  [Google Scholar]
22 Iron chelation abrogates excessive formation of hydroxyl radicals and lipid peroxidation products in monocytes of patients with Ealesę disease: Direct evidence using electron spin resonance spectroscopy
Rajesh, M., Sulochana, K.N., Ramakrishnan, S., Biswas, J., Manoharan, P.T.
Current Eye Research. 2004; 28(6): 339-407
[Pubmed]  [Google Scholar]
23 A case of juvenile vitreous hemorrhage presumably due to vitreoretinal adhesion
Uehara, J., Takeda, N., Uemura, A., Yashiro, S., Kitahashi, M., Kogahara, M.
Japanese Journal of Clinical Ophthalmology. 2004; 58(10): 1965-1968
[Pubmed]  [Google Scholar]
24 Management of vitreous haemorrhage
Saxena, S., Jalali, S., Verma, L., Pathengay, A.
Indian Journal of Ophthalmology. 2003; 51(2): 186-196
[Pubmed]  [Google Scholar]
25 Retinal neovascularization in Eales disease
Saxena, S., Kumar, D., Maitreya, A., Srivastava, P., Khanna, V.K., Nath, R., Seth, P.K.
Annals of Ophthalmology. 2003; 35(1): 25-27
[Pubmed]  [Google Scholar]
26 Presence of a 88 kDa Eales protein in uveitis, tuberculosis, leprosy and rheumatoid arthritis
Rajesh, M., Sulochana, K.N., Sundaram, A.L., Krishnakumar, S., Biswas, J., Ramakrishnan, S.
Medical Science Monitor. 2003; 9(2): CR95-CR99
[Pubmed]  [Google Scholar]
27 Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Ealesę disease)
Abu EI-Asrar, A.M., Al-Kharashi, S.A.
British Journal of Ophthalmology. 2002; 86(11): 1248-1251
[Pubmed]  [Google Scholar]
28 A long-term follow-up of Ealesę disease
Atmaca, L.S., Batioglu, F., Atmaca Sonmez, P.
Ocular Immunology and Inflammation. 2002; 10(3): 213-221
[Pubmed]  [Google Scholar]
29 Eales disease - An update
Biswas, J., Sharma, T., Gopal, L., Madhavan, H.N., Sulochana, K.N., Ramakrishnan, S.
Survey of Ophthalmology. 2002; 47(3): 197-214
[Pubmed]  [Google Scholar]
30 Further investigations on the association of Mycobacterium tuberculosis with Ealesę disease
Madhavan, H.N., Therese, K.L., Doraiswamy, K.
Indian Journal of Ophthalmology. 2002; 50(1): 35-39
[Pubmed]  [Google Scholar]
31 Cytological study on vitreous extracts in Eales disease
Juan, L., Maonian, Z.
Chinese Ophthalmic Research. 2001; 19(3): 217-219
[Pubmed]  [Google Scholar]
32 Purification and characterization of a novel 88 kDa protein from serum and vitreous of patients with Ealesę disease
Sulochana, K.N., Rajesh, M., Ramakrishnan, S.
Experimental Eye Research. 2001; 73(4): 547-555
[Pubmed]  [Google Scholar]
33 Presumed ealesę disease with neurologic involvement: Report of three cases
Biswas, J., Raghavendran, R., Pinakin, G., Arjundas, D.
Retina. 2001; 21(2): 141-145
[Pubmed]  [Google Scholar]
34 Polymerase chain reaction for detection of Mycobacterium tuberculosis in epiretinal membrane in Ealesę disease
Madhavan, H.N., Therese, K.L., Gunisha, P., Jayanthi, U., Biswas, J.
Investigative Ophthalmology and Visual Science. 2000; 41(3): 822-825
[Pubmed]  [Google Scholar]
35 Diagnostic and therapeutic approach to patients with retinal vasculitis
Stanford, M.R., Verity, D.H.
International Ophthalmology Clinics. 2000; 40(2): 69-83
[Pubmed]  [Google Scholar]
36 Ocular neovascularization in patients with uveitis
Kuo, I.C., Cunningham Jr., E.T.
International Ophthalmology Clinics. 2000; 40(2): 111-126
[Pubmed]  [Google Scholar]
37 Raised platelet thiobarbituric acid-reacting substances in proliferative Ealesę disease
Srivastava, P., Saxena, S., Khanna, V.K., Kumar, D., Nath, R., Seth, P.K.
Indian Journal of Ophthalmology. 2000; 48(4): 307-309
[Pubmed]  [Google Scholar]
38 Macular involvement Eales disease
Saxena, S., Kumar, D.
Annals of Ophthalmology - Glaucoma. 2000; 32(2): 98-100
[Pubmed]  [Google Scholar]
39 Retinal vasculitis
Levy-Clarke, G.A., Nussenblatt, R.
International Ophthalmology Clinics. 200; 45(2): 99-113
[Pubmed]  [Google Scholar]
40 Vitreoschisis in Ealesę disease: Pathogenic role and significance in surgery
Badrinath, S.S., Gopal, L., Sharma, T., Parikh, S., Shanmugam, M.P., Bhende, P., Biswas, J.
Retina. 1999; 19(1): 51-54
[Pubmed]  [Google Scholar]
41 Visual outcome in ealesę disease with branch retinal vein occlusion
Saxena, S., Kumar, D.
Annals of Ophthalmology - Glaucoma. 1999; 31(3): 173-175
[Pubmed]  [Google Scholar]
42 A 32-year-old man with vitreous hemorrhage and mediastinal lymphadenopathy
Scully, R.E., Mark, E.J., McNeely, W.F., Ebeling, S.H., Phillips, L.D.
New England Journal of Medicine. 1998; 338(5): 313-319
[Pubmed]  [Google Scholar]
43 Profiling of human leukocyte antigens in Ealesę disease
Biswas, J., Mukesh, B.N., Narain, S., Roy, S., Madhavan, H.N.
International Ophthalmology. 1997; 21(5): 227-281
[Pubmed]  [Google Scholar]
44 Ealesę disease: Accumulation of reactive oxygen intermediates and lipid peroxides and decrease of antioxidants causing inflammation, neovascularization and retinal damage
Bhooma, V., Sulochana, K.N., Biswas, J., Ramakrishnan, S.
Current Eye Research. 1997; 16(2): 91-95
[Pubmed]  [Google Scholar]
45 Noninfectious posterior uveitis
Walker, J.D., Mitchel Opremcak, E.
Seminars in Ophthalmology. 1996; 11(1): 38-56
[Pubmed]  [Google Scholar]
46 Stroke - A rare presentation of Ealesę disease: A case report
Misra, U.K., Jha, S., Kalita, J., Sharma, K.
Angiology. 1996; 47(1): 73-76
[Pubmed]  [Google Scholar]

 

Read this article